Dual vs. single surgeon in spinal deformity correction: a meta-analysis
Spine Deformity · 2026-07 · 14 (4) · 1237-1255
DOI: 10.1007/s43390-026-01330-0 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Spine Deformity, online erschienen am 16.04.2026. Verfasst von Marc Boutros und 5 weiteren Autor:innen. Beteiligte Einrichtung: Université Saint-Joseph de Beyrouth, Beyrouth, 11-5076, Lebanon. Hauptthemen laut MEDLINE: Spinal Curvatures, Scoliosis, Orthopedic Procedures, Surgeons. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND CONTEXT: Spinal deformity correction is technically demanding and often associated with extended operative time, substantial blood loss, and elevated complication rates. Dual-attending surgeon (DS) models have emerged as a strategy to enhance operative efficiency and patient safety, though published outcomes remain inconsistent. PURPOSE: To evaluate the impact of a DS approach compared with a traditional single-attending surgeon (SS) strategy on perioperative and postoperative outcomes in spinal deformity surgery. STUDY DESIGN/SETTING: Meta-analysis of comparative studies assessing DS versus SS procedures for spinal deformity correction. METHODS: A systematic literature search was performed across PubMed, Scopus, the Cochrane Library, and Google Scholar through November 6, 2025. Seventeen studies met inclusion criteria. DS cases were defined as procedures performed by two attending surgeons; SS cases involved one attending assisted by non-attending personnel. Extracted outcomes included operative time, blood loss, transfusion requirements, hospital length of stay, radiographic correction (Cobb angle), complications, readmission, and revision rates. RESULTS: The DS approach was associated with significantly reduced operative time (MD - 109.69 min; 95% CI - 145.04 to - 74.34; p < 0.00001), intraoperative blood loss (MD - 308.90 mL; 95% CI - 454.96 to - 162.83; p < 0.00001), and hospital length of stay (MD - 0.99 days; 95% CI - 1.46 to - 0.52; p < 0.00001). Transfusion risk was also lower in DS cases (RR 0.11; 95% CI 0.03-0.45; p = 0.002). No significant differences were observed in Cobb angle correction (p = 0.84), readmission rates (p = 0.11), revision rates (p = 0.54), or overall complication rates (p = 0.07). Follow-up durations were similar within individual studies but varied across the included literature. CONCLUSIONS: A DS strategy improves operative efficiency and reduces perioperative blood loss and transfusion requirements, while maintaining equivalent radiographic correction and comparable postoperative outcomes versus the SS model. These findings support selective use of DS approaches, particularly for complex or high-risk deformity cases. Further prospective studies with standardized follow-up and economic analyses are needed to clarify long-term value and cost-effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Saint-Joseph de Beyrouth, Beyrouth, 11-5076, Lebanon.
- Université Saint-Joseph de Beyrouth, Beyrouth, 11-5076, Lebanon. shazahammad17@gmail.com.
- Department of Pediatric Orthopedics, Texas Children's Hospital, Houston, TX, USA.
- Hospital for Special Surgery, 541 East 71st St, New York, NY, 10021, USA.
Zitieren
APA
Boutros, M., Awad, G., Hammad, S., Al Khatib, R., Smadi, Z., & Lovecchio, F. C. (2026). Dual vs. single surgeon in spinal deformity correction: a meta-analysis. Spine Deformity, 14(4), 1237-1255. https://doi.org/10.1007/s43390-026-01330-0
Vancouver
Boutros M, Awad G, Hammad S, Al Khatib R, Smadi Z, Lovecchio FC. Dual vs. single surgeon in spinal deformity correction: a meta-analysis. Spine Deformity. 2026;14(4):1237-1255. doi:10.1007/s43390-026-01330-0
BibTeX
@article{Boutros2026,
author = {Boutros, Marc and Awad, Guy and Hammad, Shaza and Al Khatib, Reina and Smadi, Zina and Lovecchio, Francis C},
title = {Dual vs. single surgeon in spinal deformity correction: a meta-analysis},
journal = {Spine Deformity},
year = {2026},
volume = {14},
number = {4},
pages = {1237--1255},
doi = {10.1007/s43390-026-01330-0}
}
EUVIMED